FDA Clearance Tracker · P140018
VENASEAL CLOSURE SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 20, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Feb 20, 2015
Approved
Time to decision
179 days
Received Aug 25, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P140018
- Device name
- VENASEAL CLOSURE SYSTEM
- Applicant
- Medtronic Vascular, Inc.
- Applicant location
- Plymouth, MN
- Received
- Aug 25, 2014
- Decided
- Feb 20, 2015
- Decision
- Approved
- Supplements
- 47 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Agent, occluding, vascular, permanent (PJQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE VENASEAL CLOSURE SYSTEM. THIS DEVICE IS INDICATED FOR THE PERMANENT CLOSURE OF LOWER EXTREMITY SUPERFICIAL TRUNCAL VEINS, SUCH AS THE GREAT SAPHENOUS VEIN (GSV), THROUGH ENDOVASCULAR EMBOLIZATION WITH COAPTATION. VENASEAL IS INTENDED FOR USE IN ADULTS WITH CLINICALLY SYMPTOMATIC VENOUS REFLUX AS DIAGNOSED BY DUPLEX ULTRASOUND (DUS).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PJQ (Agent, occluding, vascular, permanent).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202800 · Decided Nov 18, 2020 · 56 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
P200026 · Decided Oct 21, 2020 · 177 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
P190008 · Decided Nov 21, 2019 · 232 days after receipt
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.